Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | citrate | 0.6929 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7135 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7267 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7451 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7531 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7656 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7709 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7721 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7728 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7777 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.7780 | scaled units | Placebo | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8000 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8007 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8074 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8136 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8358 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.8408 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.8548 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8570 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8593 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.8615 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8685 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8705 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8741 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8793 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.8832 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.8836 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8845 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8882 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.8890 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.8959 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.8968 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.8986 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.8995 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9041 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9047 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9056 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9116 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9119 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9138 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9140 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9171 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9189 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9234 | scaled units | Placebo | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9281 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9308 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9332 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9364 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9404 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9430 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9452 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.9455 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9466 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9472 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9492 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.9514 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9514 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.9526 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9544 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9547 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9554 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9612 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9632 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9633 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9634 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9643 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9646 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9677 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9683 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9684 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9709 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9711 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9721 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.9730 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9734 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.9735 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.9743 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9753 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9777 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.9783 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9790 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9796 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9857 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9858 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9890 | scaled units | High-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9894 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9960 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 0.9961 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9967 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9971 | scaled units | Placebo | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9977 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 0.9981 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 0.9998 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0000 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0002 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0007 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0012 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0012 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0013 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0015 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0015 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0019 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0025 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0027 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0045 | scaled units | Placebo | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0060 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0063 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0185 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0211 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0224 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0227 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0231 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0286 | scaled units | Placebo | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0295 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0358 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0367 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0400 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0414 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0447 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0462 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0469 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0472 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0483 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0539 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0546 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0552 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0561 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0615 | scaled units | Placebo | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0620 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0633 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0640 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0645 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0689 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0708 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0751 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.0757 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0768 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0791 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0825 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0843 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.0932 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0984 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.0991 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.1001 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1001 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1019 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1025 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1028 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.1154 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1183 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.1199 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1246 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1284 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.1377 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.1408 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1418 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.1424 | scaled units | High-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.1498 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.1499 | scaled units | High-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.1540 | scaled units | Low-Dose | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.1565 | scaled units | Low-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1572 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1634 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1653 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1705 | scaled units | Placebo | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1727 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1858 | scaled units | Low-Dose | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1956 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.1970 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.2078 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.2308 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.2356 | scaled units | High-Dose | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.2415 | scaled units | High-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.2494 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.2513 | scaled units | Placebo | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.2767 | scaled units | Placebo | +23HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.3101 | scaled units | Placebo | -0.5HR |
Reversed phase NEGATIVE ION MODE | citrate | 1.3116 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.3519 | scaled units | Low-Dose | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.3574 | scaled units | High-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.3617 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.3625 | scaled units | Low-Dose | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.3635 | scaled units | Placebo | BASELINE |
Reversed phase NEGATIVE ION MODE | citrate | 1.3687 | scaled units | Placebo | +4HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.4000 | scaled units | Placebo | +47HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.4050 | scaled units | Low-Dose | +71HR POST INFUSION |
Reversed phase NEGATIVE ION MODE | citrate | 1.4237 | scaled units | Placebo | +4HR POST INFUSION |